Clinical Trial Update: Thoraflex Hybrid Post-Market Study

View source ↗

Summary

Post-market study update for Thoraflex Hybrid by Vascutek Ltd., with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Dissection
• Aortic Rupture
• Penetrating Aortic Ulcer
• Thoracic Aortic Aneurysm

Drugs mentioned

• Thoraflex Hybrid

Snippet

Sponsor: Vascutek Ltd. | Conditions: Acute Aortic Dissection, Aortic Rupture | Status: ACTIVE_NOT_RECRUITING